Director, Product Communications
MindMed
This listing was originally posted on MindMed's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moDefinium Therapeutics is a late-stage clinical biopharmaceutical and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!
We are seeking a seasoned, dynamic Director, Product Communications to lead strategic communications for the company’s late-stage pipeline, including Phase 3 data readouts, potential regulatory filings, and future launch readiness. This role will be central to shaping the external and internal narrative around Definium’s scientific rigor and innovation, stewarding corporate and product reputation through critical clinical milestones, and helping prepare the market for a potential first-in-class launch.
This individual will report into the VP of Corporate Communications, and will work in close partnership with Commercial, Medical Affairs, Investor Relations, Human Resources, Patient Advocacy, Government Affairs, and other cross-functional leaders to develop clear, compliant, and high-impact messaging and programming across earned, owned, social/digital, and shared channels. The goal is to ensure Definium’s story is communicated with consistency, credibility, and relevance to key stakeholders, including employees, patients, healthcare providers, investors, and payers.
The ideal candidate is an experienced communications professional with deep pharmaceutical experience who can operate strategically and execute flawlessly in a fast-paced, high-visibility, environment.
Responsibilities:
Qualifications:
The starting base pay range for this position is $192,904.00 - $226,600.00. Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location.
Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at MindMed?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Psychedelic-Inspired Drugs
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo